Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Pancreatic Neoplasms 11Neoplasms 4Stomach Neoplasms 2Small Cell Lung Carcinoma 2Metastatic Pancreatic Adenocarcinoma 2Colorectal Neoplasms 2Triple Negative Breast Neoplasms 1Solid Tumor 1Refractory Solid Tumors 1Pancreatic cancer, adult 1Pancreatic Diseases 1Pancreatic Cancer Non-resectable 1Ovarian Neoplasms 1Neoplasm Metastasis 1Metastatic Adenocarcinoma of the Pancreas 1Malignant Tumor of Pancreas Metastatic to Liver 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Endocrine Gland Neoplasms 1Digestive System Neoplasms 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Pancreatic Ductal 1Carcinoma, Islet Cell 1Biliary Tract Neoplasms 1Advanced Solid Tumors 1Advanced Pancreatic Cancer 1Advanced Esophageal Squamous Cell Cancer 1Advanced Breast Cancer 1Adenoma, Islet Cell 1

Interventions

pembrolizumab 98Gemcitabine 70Paclitaxel 59Docetaxel 52Carboplatin 49Cisplatin 40Nivolumab 39Capecitabine 35Pemetrexed 33Fluorouracil 32Bevacizumab 32Cetuximab 31130-nm albumin-bound paclitaxel 28Trastuzumab 26Irinotecan 24Albumin-Bound Paclitaxel 24Fulvestrant 22Leucovorin 20Oxaliplatin 18Panitumumab 17abemaciclib 16Ipilimumab 16Cyclophosphamide 15cemiplimab 14atezolizumab 14Letrozole 14palbociclib 12Lapatinib 12Drug Therapy 12Doxorubicin 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Neoplasm Metastasis × irinotecan sucrosofate × Clear all
NCT05382559 2026-04-14

A Study of ASP3082 in Adults With Advanced Solid Tumors

Astellas Pharma Inc

Phase 1 Recruiting
681 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡